Ranbaxy Laboratories News

Move comes after Indian drug-maker submitted required audit documents. The US Department of Justice today withdrew a motion against Ranbaxy Laboratories after India's biggest drugmaker submitted a comprehensive ...

Share prices of India's largest drug maker Ranbaxy Laboratories gained 9.08 percent on the Bombay Stock Exchange after the company confirmed in a regulatory statement Wednesday that the US Department of Justice ...

Q: I heard that the FDA has blocked some drug imports from India. What can you tell me about this? A: The FDA recently issued two Warning Letters and an Import Alert to Ranbaxy Laboratories, India's largest ...

Stringent regulatory norms and the financial impact of the global credit crisis on some research companies may hurt half a dozen molecules of Indian companies, such as Glenmark, Nicholas Piramal and Ranbaxy ...

NEW DELHI: The government on Friday approved the acquisition of drug company Ranbaxy Laboratories by Japanese pharma major Daiichi Sankyo envisaging foreign investment of around Rs 21,500 crore.

Ranbaxy Laboratories will focus on monetisation of Para-IV ANDAs with 18-20 first-to-file products with market size of around $26 billion valued at innovator prices.

Thursday, 25 September 2008, 3:06 pm Press Release: Ministry of Health Media release Voluntary quarantine of Ranbaxy drugs in place New Zealand's reaction to the United States Food and Drug Administration ...

Ranbaxy Laboratories says all of its drugs are safe, including those supplied to African countries to fight AIDS.

MUMBAI: Recovery in equities, led by spurt in shares of oil & gas major Reliance Industries, was short-lived as investors intensified profit booking.

Ranbaxy Laboratories has said that all its medicines, including the AIDS drugs supplied to African countries under United States government supported programmes, are safe and effective.

FDA Issues Warning Letters to Ranbaxy Laboratories and an Import Alert for Drugs from Two Ranbaxy Plants in India 9/16/2008 The Food and Drug Administration today issued two Warning Letters to Ranbaxy ...

NEW YORK: Ranbaxy Laboratories has hired former New York Mayor Rudolph Giuliani as an advisor after the U.S. blocked imports of 30 of its generic drugs citing manufacturing deficiencies.

Indian pharmaceutical giant Ranbaxy Laboratories has hired former New York Mayor Rudolph Giuliani as an advisor after the US blocked imports of 30 of its generic drugs citing manufacturing deficiencies.

Medsafe is checking drugs imported from India are being made correctly. Ranbaxy Laboratories has failed a US Food and Drug Administration audit at two of its sites over the way it manufactures its drugs.

With the company not being able to sell a part of its generics portfolio in the US market, revenues and profits could suffer.

Ranbaxy Laboratories Ltd., today announced that they have retained the services of former New York City Mayor Rudy Giuliani and Giuliani Partners to provide advice and review compliance issues related to the ...

MUMBAI: After a promising start, stocks fell sharply on continued selling by funds in heavyweight stocks amid profit-taking. Realty and banking stocks were the worst hit.

Mumbai : Shares of Ranbaxy Laboratories on wednesday suffered massive setback on the bourses and settled with a loss of nearly seven per cent after the US health regulator blocked imports of generic drugs ...

On Tuesday, the FDA barred Ranbaxy from importing a raft of drugs - including generic versions of the popular antibiotic Cipro and the cholesterol pill Zocor - citing poor quality at two Ranbaxy factories in ...

WASHINGTON The government is closing U.S. borders to more than 30 generic drugs - including popular antibiotics and cholesterol medicines - made by India's drug giant Ranbaxy Laboratories because of poor ...